Azenta officer files initial Form 3

Azenta, Inc. filed an initial Form 3 for William E. Martin III, who serves as President Multiomics.

Rhea-AI Filing Summary

Azenta, Inc. filed an initial Form 3 for William E. Martin III, who serves as President Multiomics. This filing establishes his status as a reporting officer of the company. The Form 3 shows no reported transactions or holdings in Azenta securities in this submission.

Key Figures

Insider buy transactions: 0 transactions Insider sell transactions: 0 transactions Derivative exercises: 0 shares

3 metrics

Insider buy transactions 0 transactions BuyCount in transaction summary

Insider sell transactions 0 transactions SellCount in transaction summary

Derivative exercises 0 shares ExerciseShares in transaction summary

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Azenta (AZTA) Form 3 filing for William E. Martin III show?

The Form 3 shows that William E. Martin III is an officer of Azenta, serving as President Multiomics. It is an initial statement of beneficial ownership and in this filing no transactions or holdings are reported.

Who is the reporting person in the Azenta (AZTA) Form 3 filing?

The reporting person is William E. Martin III, identified as an officer of Azenta with the title President Multiomics. This establishes him as subject to insider reporting requirements for the company’s securities.

Does the Azenta (AZTA) Form 3 report any insider share purchases or sales?

No purchases or sales are reported. The transaction summary shows zero buy, sell, exercise, gift, tax withholding, or restructuring transactions, indicating no insider trading activity is disclosed in this particular Form 3.

Are any derivative securities reported in the Azenta (AZTA) Form 3?

No derivative securities are reported. The derivative summary is empty and the transaction summary lists zero derivative transactions or exercises, meaning no options or other derivative positions are disclosed in this Form 3.

What is the purpose of this Azenta (AZTA) Form 3 insider filing?

This Form 3 serves as an initial statement of beneficial ownership for officer William E. Martin III. It formally registers him as an insider of Azenta for SEC reporting, even though no specific security holdings or transactions are reported here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 06:48 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

MARTIN WILLIAM E. III

(Last) (First) (Middle)

C/O AZENTA, INC.

200 SUMMIT DRIVE, 6TH FLOOR

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/06/2026

3. Issuer Name and Ticker or Trading Symbol
Azenta, Inc. [ AZTA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President Multiomics

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/Ephraim Starr, Attorney-in-fact for William E. Martin III	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)